Crossover Study: Nanomicellar Cyclosporine 0.09% vs Emulsion Cyclosporine 0.05%
A panelist discusses how the COAT trial showed that switching patients with uncontrolled dry eye disease on cyclosporine 0.05% to the 0.09% solution led to significant improvements in corneal staining and symptoms by week 4, offering earlier relief than …